has invited you to join this group
This discussion centers on using checkpoint inhibitors to manage squamous cell carcinoma of the head and neck (SCCHN).
Nov 14, 2019
11:00 am UTC
Nov 23, 2019
3:58 am UTC
You're much more likely to get a response if you explain why you're reaching out.
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
Associate Director, Moore Cancer Center; Professor of Medicine